Fabry disease: Four case reports of meningioma and a review of the literature on other malignancies
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by loss of function mutations in the GLA gene at Xq22 with subsequent functional deficiency of alpha-galactosidase A, resulting in the accumulation of globotriaosylceramide (GL-3 or Gb3) in multiple cells types throughout the body....
Main Authors: | Beth L. Thurberg, MD, PhD, Dominique P. Germain, MD, PhD, Fernando Perretta, MD, Iulia E. Jurca-Simina, MD, Juan M. Politei, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426916300866 |
Similar Items
-
Characterization of small fiber pathology in a mouse model of Fabry disease
by: Lukas Hofmann, et al.
Published: (2018-10-01) -
Genomic analysis of Brazilian patients with Fabry disease
by: F.S. Pereira, et al.
Published: (2007-12-01) -
Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
by: Takahiro Tsukimura, et al.
Published: (2021-09-01) -
The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein
by: Michael P. Nelson, et al.
Published: (2018-02-01) -
Sensory-specific peripheral nerve pathology in a rat model of Fabry disease
by: Tyler B. Waltz, et al.
Published: (2021-08-01)